5443192026-05-085443192026-05-082026-05-08xbrli:pureSENORESSENORES PHARMACEUTICALS LIMITEDfalseINE0RB801010Board MeetingNew2026-05-14true2026-04-0116-04-20262026-05-08Financial resultsOther businessAuditedStandalone And ConsolidatedYearlyMarch2026Further, in this connection, please refer our earlier intimation dated March 27, 2026, whereby, pursuant to the Company’s Code of Conduct framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended (“the Code”), the Trading Window for dealing in securities of the Company, for persons specified under the Code, was closed from April 01, 2026 till 48 hours after the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year March 31, 2026 are approved by the Board of Directors and submitted to Stock Exchanges.